Topo Therapeutics, Inc. — Form D/A
Topo Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2024-12-31. The offering totals $95.0M, of which $10.6M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-12-31
- Form: D/A
- Accession: 0002049947-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $95.0M
- Amount sold: $10.6M
- Remaining: $84.4M
- Investors: 4
- Date of first sale: 2024-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-533637
Issuer
- Name: Topo Therapeutics, Inc.
- CIK: 0002049947
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2024
- Address: ONE KENDALL SQUARE, CAMBRIDGE, MA, 02139
- Phone: 857-331-6825
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Bruce Jeffrey Bean | Director | Cambridge, MA |
| James Jeffrey Goater, Jr. | Director | Cambridge, MA |
| Karin Jeffrey Kleinhans | Director | Cambridge, MA |
| Madgalene Moran | Director | Cambridge, MA |
| Hui Tian | Director | Cambridge, MA |
| Madgalene Moran | Executive Officer | Cambridge, MA |
| Hui Tian | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More